| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.023 | 0.4 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |